Knockdown of SOX2OT Inhibits the Malignant Biological Behaviors of Glioblastoma Stem Cells Via Up-regulating the Expression of MiR-194-5p and MiR-122
Overview
Oncology
Authors
Affiliations
Background: Accumulating evidence has highlighted the potential role of long non-coding RNAs (lncRNAs) in the biological behaviors of glioblastoma stem cells (GSCs). Here, we elucidated the function and possible molecular mechanisms of the effect of lncRNA-SOX2OT on the biological behaviors of GSCs.
Results: Real-time PCR demonstrated that SOX2OT expression was up-regulated in glioma tissues and GSCs. Knockdown of SOX2OT inhibited the proliferation, migration and invasion of GSCs, and promoted GSCs apoptosis. MiR-194-5p and miR-122 were down-regulated in human glioma tissues and GSCs, and miR-194-5p and miR-122 respectively exerted tumor-suppressive functions by inhibiting the proliferation, migration and invasion of GSCs, while promoting GSCs apoptosis. Knockdown of SOX2OT significantly increased the expression of miR-194-5p and miR-122 in GSCs. Dual-luciferase reporter assay revealed that SOX2OT bound to both miR-194-5p and miR-122. SOX3 and TDGF-1 were up-regulated in human glioma tissues and GSCs. Knockdown of SOX3 inhibited the proliferation, migration and invasion of GSCs, promoted GSCs apoptosis, and decreased TDGF-1 mRNA and protein expression through direct binding to the TDGF-1 promoter. Over-expression of miR-194-5p and miR-122 decreased the mRNA and protein expression of SOX3 by targeting its 3'UTR. Knockdown of TDGF-1 inhibited the proliferation, migration and invasion of GSCs, promoted GSCs apoptosis, and inhibited the JAK/STAT signaling pathway. Furthermore, SOX3 knockdown also inhibited the SOX2OT expression through direct binding to the SOX2OT promoter and formed a positive feedback loop.
Conclusion: This study is the first to demonstrate that the SOX2OT-miR-194-5p/miR-122-SOX3-TDGF-1 pathway forms a positive feedback loop and regulates the biological behaviors of GSCs, and these findings might provide a novel strategy for glioma treatment.
The emerging role of long non-coding RNA SOX2-OT in cancers and non-malignant diseases.
Yang J, Tan F, Chen Y, Li X, Yuan C J Physiol Biochem. 2024; .
PMID: 39702742 DOI: 10.1007/s13105-024-01059-2.
Doghish A, Abd-Elmawla M, Hatawsh A, Zaki M, Aborehab N, Radwan A Metab Brain Dis. 2024; 40(1):42.
PMID: 39589598 DOI: 10.1007/s11011-024-01456-y.
Wang X, Sun Q, Liu T, Lu H, Lin X, Wang W Sci Adv. 2024; 10(47):eadn4306.
PMID: 39576855 PMC: 11584018. DOI: 10.1126/sciadv.adn4306.
LncRNAs SOX2-OT and NEAT1 act as a potential biomarker for esophageal squamous cell carcinoma.
Kumar R, Mohanta A, Rana M, Uttam V, Tuli H, Jain A Discov Oncol. 2024; 15(1):693.
PMID: 39576275 PMC: 11584831. DOI: 10.1007/s12672-024-01589-7.
Aria H, Azizi M, Nazem S, Mansoori B, Darbeheshti F, Niazmand A Heliyon. 2024; 10(15):e35208.
PMID: 39170516 PMC: 11337742. DOI: 10.1016/j.heliyon.2024.e35208.